Diphtheria's Resurgence: A Health Crisis Ignited by Conflict
Diphtheria is re-emerging, especially in areas affected by conflict and low vaccination rates.
― 6 min read
Table of Contents
Diphtheria is not just a long, hard-to-pronounce word; it's a serious disease caused by a bacterium named Corynebacterium diphtheriae. While it used to be a big problem, especially for kids, some smart folks came up with a vaccine and effective treatments to help keep it at bay. Thanks to the hard work of health organizations, the number of diphtheria Cases dropped significantly, and we saw a steep decline in deaths related to the disease.
The Road to Recovery
In the past, diphtheria was like that annoying relative who just wouldn't leave. It caused many health issues and deaths among children. However, the introduction of the diphtheria-tetanus-pertussis vaccine, along with better treatments, has played a huge role in reducing the number of cases. By the mid-2010s, cases had dropped to around 5,000 per year worldwide, which was nothing short of a victory for public health.
However, just when we thought we had it all figured out, diphtheria decided to make a comeback. Although it hasn't returned everywhere equally, certain areas have been hit hard. This resurgence is a reminder that we can't let our guard down, especially when it comes to diseases like diphtheria.
Treatment Dilemmas
When it comes to treating diphtheria, timing is key. Doctors need to quickly give antibiotics and diphtheria antitoxin (DAT) to patients. Antibiotics help get rid of the bacteria causing the problem, while DAT is crucial for preventing severe complications. However, after years of low demand for DAT due to Vaccination success, production decreased, and stockpiles dwindled. Now, public health agencies face challenges in maintaining supplies of this important treatment.
Unfortunately, when treatment is delayed, the effectiveness of DAT drops. That's why having enough DAT on hand is vital for preventing deaths in diphtheria cases.
The Impact of Vaccination
Vaccination is the best defense we have against diphtheria. Unfortunately, the rates of vaccination can greatly affect how much diphtheria shows up in various areas. Case fatality rates (CFRs) can range dramatically, from as low as 0.6% to as high as 69%. The average CFR dropped to about 7% in the mid-20th century, but modern outbreaks have shown more variability, largely due to differing vaccine coverage and access to DAT.
How Conflict Influences Disease
Interestingly, the last few decades have shown a connection between outbreaks of diphtheria and places experiencing conflict or civil unrest. Areas affected by war or political issues, such as parts of Yemen and Nigeria, have seen increased diphtheria cases. Displacement of populations due to conflict often leads to poor access to healthcare and vaccines, creating the perfect storm for disease resurgence.
Research has suggested that areas currently experiencing conflict can see a significant increase in the risk of diphtheria outbreaks. For example, conflict can strain healthcare systems, leading to lower vaccination coverage.
Unearthing the Risk Factors
With this knowledge in hand, researchers are keen to learn more about the risk of diphtheria in regions with conflict. It is crucial to know how armed conflict and vaccination rates intersect, as this can help in preparing for potential outbreaks.
When looking at the World Health Organization's plan for disease prevention, three steps stand out:
- Promoting vaccine coverage.
- Keeping track of new cases and vaccination rates.
- Being ready for emergencies.
Using this framework, scientists are working to understand how conflict can lead to higher diphtheria rates. They suspect that armed conflict might affect health systems in two main ways: by reducing vaccination coverage or by disrupting the ability to monitor cases effectively.
How the Research Works
In their quest for answers, researchers turned to data from the WHO's African region, which has seen a surge in diphtheria cases. By examining vaccination rates and conflict-related data, they hope to find patterns that could predict outbreaks.
This research involved looking at the number of diphtheria cases reported between 2017 and 2024, alongside the amount of conflict in the same regions. The goal is to see if there's a connection between high conflict rates and the emergence of diphtheria again.
The Numbers Game
The researchers looked at data from various regions and found that 47 states reported diphtheria at least once during the study period. They noticed that regions with diphtheria also had higher rates of conflict-related fatalities. In fact, the average number of fatalities was significantly higher in areas where diphtheria was reported.
Additionally, they found that childhood vaccination rates were lower in areas where diphtheria was present. This paints a clear picture that low vaccination gets along just too well with high rates of conflict, creating an environment conducive to the disease.
The Model Breakdown
To further analyze the data, researchers built a statistical model to assess the relationship between conflict, vaccination rates, and diphtheria outbreaks. They discovered that a higher number of conflict-related fatalities was linked to an increased risk of reporting diphtheria cases. In fact, the odds of diphtheria were significantly higher in regions with a history of severe conflict.
Interestingly, the relationship between vaccination coverage and diphtheria was not straightforward. Instead of a clear protective effect of high vaccination rates, they found a more complex relationship where areas with medium vaccination coverage (between 50% - 80%) also reported a spike in diphtheria cases.
What Does This Mean?
The findings suggest that while vaccination is crucial, it is not the only factor influencing diphtheria outbreaks. Conflicts disrupt healthcare services, making it harder for people to get vaccinated and access care for the disease.
For regions caught in conflict, even high vaccination coverage might not be enough. The chaos of war and unrest can lead to poor health infrastructure, making it harder to keep track of cases and respond to outbreaks.
Planning for the Future
Given the relationship between conflict and diphtheria, public health officials must work to boost vaccine coverage and prepare for potential outbreaks in conflict areas. Having plans for emergency responses, training healthcare workers to recognize diphtheria symptoms quickly, and maintaining stockpiles of DAT are all essential steps.
Even if regions with severe conflict face challenges, understanding the risk of diphtheria can help guide resource planning. Knowing which areas are at risk can inform healthcare efforts and prepare for the worst.
Limitations and Future Directions
This research does have its limitations. Reporting of diphtheria cases is likely underestimated, especially in places with unstable health systems. If all cases were accurately reported, connections to conflict would be even stronger.
Additionally, this research does not consider diphtheria outbreaks in neighboring countries or the time-related factors of the data. Future studies should explore these aspects further and refine the understanding of diphtheria outbreak risks.
Conclusion
In summary, diphtheria may be a historical concern, but it’s making unexpected returns, especially in conflict-ridden areas. While vaccination is a key tool in preventing the disease, understanding the impact of armed conflict is equally important. By connecting the dots between conflict, vaccination rates, and diphtheria outbreaks, health officials can better prepare for future challenges.
As the world grapples with conflicts and their effects on health, knowledge about disease patterns will be crucial. With the right insights, we can work together to keep diphtheria-and perhaps that annoying relative-away for good.
Title: A population-level analysis of armed conflict and diphtheria at the subnational level in the WHO African Region 2017-2024
Abstract: BackgroundDiphtheria has been re-emerging around the world at alarming rates, raising concerns about emergency preparedness when global supplies of life-saving diphtheria antitoxin are insufficient. Outbreaks have occurred in areas with suboptimal coverage of the three-dose diphtheria tetanus and pertussis (DTP3) vaccine and regions experiencing conflict, but systematic studies assessing the association between these variables and the risk of diphtheria emergence are limited. This population-level study aimed to investigate the relationship between fatalities from armed conflict events, childhood DTP3 vaccination coverage, and the presence of reported diphtheria cases in countries in the World Health Organizations (WHO) African region from 2017-2024. MethodsThe analysis was conducted at the subnational geographic scale of administrative level 1 (ADM1) (N countries=35, N ADM1 regions=541) from March 2017 to March 2024. We first used a univariate logistic regression model to establish a crude relationship between the ADM1 diphtheria status from 2017-2024 and the population-adjusted cumulative conflict-related fatalities from 2013-2024. We then fit three competing generalized logistic models with random effects accounting for weekly repeated measures at the ADM1 and country levels to estimate the relationship between time-varying rates of conflict-related fatalities and diphtheria status, adjusting for diphtheria vaccine coverage estimates. ResultsResults from the crude model indicate that higher ten-year cumulative rates of conflict-related fatalities are associated with a higher risk of reported diphtheria cases (OR = 1.41, 95% CI: 1.17-1.68). The results from the best-fitting repeated measures model indicate that higher rates of log-transformed conflict-related fatalities are associated with a 17.6-fold increase in diphtheria risk (OR = 17.6, 95% CI: 13.99-22.08), though risk varied widely by state and country. The best-fit model also associated lower estimates of diphtheria risk in areas with high (>80%) and low (
Authors: Tierney O’Sullivan, Lindsay T. Keegan
Last Update: Dec 20, 2024
Language: English
Source URL: https://www.medrxiv.org/content/10.1101/2024.12.18.24319262
Source PDF: https://www.medrxiv.org/content/10.1101/2024.12.18.24319262.full.pdf
Licence: https://creativecommons.org/licenses/by-nc/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to medrxiv for use of its open access interoperability.